#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vulval cancer Langerhans' cell histiocytosis Complex regional pain syndrome Malignant fibrous histiocytoma Bladder cancer Antiphospholipid antibodies X-linked lymphoproliferative syndrome Leiomyosarcoma metastatic Acute leukaemia Juvenile idiopathic arthritis Hypoparathyroidism Atypical haemolytic uraemic syndrome Arterial tortuosity syndrome T-cell lymphoma Phenylketonuria More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy – Trials in Disease Primary hyperoxaluria – Diagnostics Hyperoxaluria Angiosarcoma metastatic – Treatment Short-bowel syndrome – Basic Information Angiosarcoma non-metastatic Advanced systemic mastocytosis – Life with Disease Tuberous sclerosis complex – Basic Information Acquired haemophilia Phenylketonuria – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dexamethasone Acetate Interleukin-2 Bromocriptine Pacritinib Pyridoxine Hydrochloride Bp 177LU-PSMA-I&T Micafungin Streptococcus Agalactiae Vibozilimod HSP-CAR30 Quercetin Resatorvid Ketoprofen Lacosamide Sodium Laurilsulfate Piperacillin Monohydrate Cdr132L Sodium Bgb-15025 Citrate TRIACYLGLYCEROL LIPASE GOCATAMIG More therapies…

    Learn about Your Condition

    Hepatic angiosarcoma Arteriospasm coronary Vertebrobasilar stroke Dyslipidaemia Nervous system disorder Diabetic retinal oedema Overweight Dystonic tremor Embolism venous Prodromal Alzheimer's disease Acarodermatitis Sepsis Asthmatic crisis Vulval cancer Hyperadrenocorticism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Long-term Safety of Vedolizumab and Prednisone in Children with Ulcerative Colitis or Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    • Prednisone
    Belgium Croatia Greece Hungary Italy Poland

  • Study of Mirikizumab for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Mirikizumab
    Austria Belgium France Italy The Netherlands Norway +3

  • Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Microsatellite instability cancer
    • Rectal cancer
    Investigated Drugs:
    • Dostarlimab
    France

  • Study on Preventing Liver Recurrence in Patients with Intrahepatic Cholangiocarcinoma Using Floxuridine via Hepatic Arterial Infusion Pump

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    The Netherlands

  • Study on Upadacitinib for Children with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Sulfasalazine
    • Ciprofloxacin
    • Upadacitinib
    Belgium Bulgaria France Greece Italy Poland +1

  • Study of HM15912 for Adults with Short Bowel Syndrome-associated Intestinal Failure

    Recruiting

    2 1
    Investigated Drugs:
    • Human Glucagon-Like Peptide-2 Analogue Linked To A Human Immunoglobulin Fc Fragment
    Belgium Denmark France Germany Poland
Previous Page
1 … 19 20 21 22 23 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!